Doribax 500mg Injection
PDF Leaflet Revision Date: 28 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible bacteria.
Dosage (summary)
500 mg IV every 8 hours; adjust for renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Safety not established in pregnancy or lactation.
Key Drug Interactions
- Probenecid
- Valproic acid
Contraindications
- Hypersensitivity to doripenem or beta-lactams
Common side effects
- Nausea
- Diarrhoea
- Headache
- Phlebitis
Counselling Points
- Monitor for allergic reactions
- Report severe diarrhea
- Avoid use in absence of infection
Serious warnings
- Increased mortality in ventilator-associated pneumonia
- Serious hypersensitivity reactions
Important Disclaimer
The Doribax 500mg Injection professional information leaflet below is the property of Acino Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
